Ricerca e Innovazione

HairScience IL-17 inhibition: is it the long-awaited savior for alopecia areata?

Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence Predictive metagenomic profiling, urine metabolomics, and human marker gene expression as an integrated approach to study alopecia areata Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study ‘Omics’ approaches for studying the microbiome in Alopecia areata 598 Increasing follicular resistance to bacterial contamination: A novel antimicrobial therapy? Scalp bacterial shift in Alopecia areata.
VIEW ALL

2018

IL-17 inhibition: is it the long-awaited savior for alopecia areata?

Arch Dermatol Res 2018; 310 (5): 383-390.

Interleukin-17 (IL-17) has been implicated in the pathogenesis of a large number of inflammatory and autoimmune conditions,including skin disorders such as psoriasis. Recently, much data have accumulated on the possible role of IL-17 in the pathogenesis of alopecia areata (AA).

IL-17 inhibition: is it the long-awaited savior for alopecia areata?

Ramot Y et al.